nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluorescein—ABCC1—Mitoxantrone—multiple sclerosis	0.281	0.371	CbGbCtD
Fluorescein—ABCB11—Dexamethasone—multiple sclerosis	0.205	0.271	CbGbCtD
Fluorescein—ABCC1—Methotrexate—multiple sclerosis	0.117	0.155	CbGbCtD
Fluorescein—CYP1A1—Dexamethasone—multiple sclerosis	0.0901	0.119	CbGbCtD
Fluorescein—SLC22A6—Methotrexate—multiple sclerosis	0.0635	0.0838	CbGbCtD
Fluorescein—Bradycardia—Betamethasone—multiple sclerosis	0.000537	0.00222	CcSEcCtD
Fluorescein—Bradycardia—Dexamethasone—multiple sclerosis	0.000537	0.00222	CcSEcCtD
Fluorescein—Abdominal pain—Azathioprine—multiple sclerosis	0.000535	0.00221	CcSEcCtD
Fluorescein—Tachycardia—Mitoxantrone—multiple sclerosis	0.000534	0.00221	CcSEcCtD
Fluorescein—Skin disorder—Mitoxantrone—multiple sclerosis	0.000531	0.0022	CcSEcCtD
Fluorescein—Vomiting—Cladribine—multiple sclerosis	0.000529	0.00219	CcSEcCtD
Fluorescein—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000529	0.00219	CcSEcCtD
Fluorescein—Angiopathy—Methylprednisolone—multiple sclerosis	0.000526	0.00217	CcSEcCtD
Fluorescein—Rash—Cladribine—multiple sclerosis	0.000525	0.00217	CcSEcCtD
Fluorescein—Dermatitis—Cladribine—multiple sclerosis	0.000524	0.00217	CcSEcCtD
Fluorescein—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000524	0.00216	CcSEcCtD
Fluorescein—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000522	0.00216	CcSEcCtD
Fluorescein—Headache—Cladribine—multiple sclerosis	0.000521	0.00215	CcSEcCtD
Fluorescein—Hypotension—Mitoxantrone—multiple sclerosis	0.000511	0.00211	CcSEcCtD
Fluorescein—Ill-defined disorder—Prednisolone—multiple sclerosis	0.00051	0.00211	CcSEcCtD
Fluorescein—Erythema—Triamcinolone—multiple sclerosis	0.000506	0.00209	CcSEcCtD
Fluorescein—Erythema—Methylprednisolone—multiple sclerosis	0.000505	0.00209	CcSEcCtD
Fluorescein—Hypersensitivity—Azathioprine—multiple sclerosis	0.000499	0.00206	CcSEcCtD
Fluorescein—Malaise—Prednisolone—multiple sclerosis	0.000496	0.00205	CcSEcCtD
Fluorescein—Dysgeusia—Triamcinolone—multiple sclerosis	0.000495	0.00205	CcSEcCtD
Fluorescein—Nausea—Cladribine—multiple sclerosis	0.000494	0.00204	CcSEcCtD
Fluorescein—Syncope—Prednisolone—multiple sclerosis	0.000493	0.00204	CcSEcCtD
Fluorescein—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000491	0.00203	CcSEcCtD
Fluorescein—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000488	0.00202	CcSEcCtD
Fluorescein—Loss of consciousness—Prednisolone—multiple sclerosis	0.000483	0.002	CcSEcCtD
Fluorescein—Asthma—Methotrexate—multiple sclerosis	0.000479	0.00198	CcSEcCtD
Fluorescein—Angiopathy—Betamethasone—multiple sclerosis	0.000478	0.00198	CcSEcCtD
Fluorescein—Angiopathy—Dexamethasone—multiple sclerosis	0.000478	0.00198	CcSEcCtD
Fluorescein—Convulsion—Prednisolone—multiple sclerosis	0.000476	0.00197	CcSEcCtD
Fluorescein—Hypertension—Prednisolone—multiple sclerosis	0.000475	0.00196	CcSEcCtD
Fluorescein—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000469	0.00194	CcSEcCtD
Fluorescein—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000468	0.00193	CcSEcCtD
Fluorescein—Pain—Mitoxantrone—multiple sclerosis	0.000468	0.00193	CcSEcCtD
Fluorescein—Bradycardia—Prednisone—multiple sclerosis	0.000467	0.00193	CcSEcCtD
Fluorescein—Discomfort—Prednisolone—multiple sclerosis	0.000463	0.00191	CcSEcCtD
Fluorescein—Abdominal discomfort—Methotrexate—multiple sclerosis	0.00046	0.0019	CcSEcCtD
Fluorescein—Erythema—Betamethasone—multiple sclerosis	0.000459	0.0019	CcSEcCtD
Fluorescein—Erythema—Dexamethasone—multiple sclerosis	0.000459	0.0019	CcSEcCtD
Fluorescein—Malaise—Triamcinolone—multiple sclerosis	0.000456	0.00188	CcSEcCtD
Fluorescein—Malaise—Methylprednisolone—multiple sclerosis	0.000455	0.00188	CcSEcCtD
Fluorescein—Syncope—Triamcinolone—multiple sclerosis	0.000454	0.00187	CcSEcCtD
Fluorescein—Syncope—Methylprednisolone—multiple sclerosis	0.000453	0.00187	CcSEcCtD
Fluorescein—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000451	0.00186	CcSEcCtD
Fluorescein—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000449	0.00185	CcSEcCtD
Fluorescein—Oedema—Prednisolone—multiple sclerosis	0.000449	0.00185	CcSEcCtD
Fluorescein—Dizziness—Azathioprine—multiple sclerosis	0.000448	0.00185	CcSEcCtD
Fluorescein—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000447	0.00185	CcSEcCtD
Fluorescein—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000445	0.00184	CcSEcCtD
Fluorescein—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000444	0.00183	CcSEcCtD
Fluorescein—Shock—Prednisolone—multiple sclerosis	0.000442	0.00182	CcSEcCtD
Fluorescein—Cough—Triamcinolone—multiple sclerosis	0.000441	0.00182	CcSEcCtD
Fluorescein—Convulsion—Triamcinolone—multiple sclerosis	0.000438	0.00181	CcSEcCtD
Fluorescein—Tachycardia—Prednisolone—multiple sclerosis	0.000438	0.00181	CcSEcCtD
Fluorescein—Convulsion—Methylprednisolone—multiple sclerosis	0.000437	0.00181	CcSEcCtD
Fluorescein—Hypertension—Triamcinolone—multiple sclerosis	0.000437	0.0018	CcSEcCtD
Fluorescein—Hypertension—Methylprednisolone—multiple sclerosis	0.000436	0.0018	CcSEcCtD
Fluorescein—Urticaria—Mitoxantrone—multiple sclerosis	0.000435	0.0018	CcSEcCtD
Fluorescein—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000434	0.00179	CcSEcCtD
Fluorescein—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000432	0.00179	CcSEcCtD
Fluorescein—Vomiting—Azathioprine—multiple sclerosis	0.00043	0.00178	CcSEcCtD
Fluorescein—Rash—Azathioprine—multiple sclerosis	0.000427	0.00176	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000427	0.00176	CcSEcCtD
Fluorescein—Dermatitis—Azathioprine—multiple sclerosis	0.000426	0.00176	CcSEcCtD
Fluorescein—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000426	0.00176	CcSEcCtD
Fluorescein—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000426	0.00176	CcSEcCtD
Fluorescein—Discomfort—Triamcinolone—multiple sclerosis	0.000425	0.00176	CcSEcCtD
Fluorescein—Discomfort—Methylprednisolone—multiple sclerosis	0.000424	0.00175	CcSEcCtD
Fluorescein—Headache—Azathioprine—multiple sclerosis	0.000424	0.00175	CcSEcCtD
Fluorescein—Angiopathy—Prednisone—multiple sclerosis	0.000417	0.00172	CcSEcCtD
Fluorescein—Immune system disorder—Prednisone—multiple sclerosis	0.000415	0.00171	CcSEcCtD
Fluorescein—Malaise—Betamethasone—multiple sclerosis	0.000414	0.00171	CcSEcCtD
Fluorescein—Malaise—Dexamethasone—multiple sclerosis	0.000414	0.00171	CcSEcCtD
Fluorescein—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000413	0.00171	CcSEcCtD
Fluorescein—Oedema—Triamcinolone—multiple sclerosis	0.000413	0.00171	CcSEcCtD
Fluorescein—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000412	0.0017	CcSEcCtD
Fluorescein—Syncope—Betamethasone—multiple sclerosis	0.000412	0.0017	CcSEcCtD
Fluorescein—Syncope—Dexamethasone—multiple sclerosis	0.000412	0.0017	CcSEcCtD
Fluorescein—Shock—Triamcinolone—multiple sclerosis	0.000406	0.00168	CcSEcCtD
Fluorescein—Shock—Methylprednisolone—multiple sclerosis	0.000405	0.00167	CcSEcCtD
Fluorescein—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000404	0.00167	CcSEcCtD
Fluorescein—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000403	0.00167	CcSEcCtD
Fluorescein—Loss of consciousness—Betamethasone—multiple sclerosis	0.000403	0.00167	CcSEcCtD
Fluorescein—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000403	0.00167	CcSEcCtD
Fluorescein—Paraesthesia—Prednisolone—multiple sclerosis	0.000403	0.00167	CcSEcCtD
Fluorescein—Tachycardia—Triamcinolone—multiple sclerosis	0.000403	0.00166	CcSEcCtD
Fluorescein—Nausea—Azathioprine—multiple sclerosis	0.000402	0.00166	CcSEcCtD
Fluorescein—Tachycardia—Methylprednisolone—multiple sclerosis	0.000402	0.00166	CcSEcCtD
Fluorescein—Skin disorder—Methylprednisolone—multiple sclerosis	0.0004	0.00165	CcSEcCtD
Fluorescein—Erythema—Prednisone—multiple sclerosis	0.0004	0.00165	CcSEcCtD
Fluorescein—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000399	0.00165	CcSEcCtD
Fluorescein—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000398	0.00165	CcSEcCtD
Fluorescein—Convulsion—Betamethasone—multiple sclerosis	0.000398	0.00164	CcSEcCtD
Fluorescein—Convulsion—Dexamethasone—multiple sclerosis	0.000398	0.00164	CcSEcCtD
Fluorescein—Hypertension—Betamethasone—multiple sclerosis	0.000396	0.00164	CcSEcCtD
Fluorescein—Hypertension—Dexamethasone—multiple sclerosis	0.000396	0.00164	CcSEcCtD
Fluorescein—Asthenia—Mitoxantrone—multiple sclerosis	0.000393	0.00162	CcSEcCtD
Fluorescein—Discomfort—Betamethasone—multiple sclerosis	0.000386	0.00159	CcSEcCtD
Fluorescein—Discomfort—Dexamethasone—multiple sclerosis	0.000386	0.00159	CcSEcCtD
Fluorescein—Hypotension—Methylprednisolone—multiple sclerosis	0.000385	0.00159	CcSEcCtD
Fluorescein—Pain—Prednisolone—multiple sclerosis	0.000384	0.00159	CcSEcCtD
Fluorescein—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000375	0.00155	CcSEcCtD
Fluorescein—Oedema—Dexamethasone—multiple sclerosis	0.000375	0.00155	CcSEcCtD
Fluorescein—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000375	0.00155	CcSEcCtD
Fluorescein—Oedema—Betamethasone—multiple sclerosis	0.000375	0.00155	CcSEcCtD
Fluorescein—Ill-defined disorder—Prednisone—multiple sclerosis	0.000371	0.00153	CcSEcCtD
Fluorescein—Paraesthesia—Triamcinolone—multiple sclerosis	0.000371	0.00153	CcSEcCtD
Fluorescein—Feeling abnormal—Prednisolone—multiple sclerosis	0.00037	0.00153	CcSEcCtD
Fluorescein—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00037	0.00153	CcSEcCtD
Fluorescein—Shock—Dexamethasone—multiple sclerosis	0.000368	0.00152	CcSEcCtD
Fluorescein—Shock—Betamethasone—multiple sclerosis	0.000368	0.00152	CcSEcCtD
Fluorescein—Dyspnoea—Triamcinolone—multiple sclerosis	0.000368	0.00152	CcSEcCtD
Fluorescein—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000367	0.00152	CcSEcCtD
Fluorescein—Nervous system disorder—Betamethasone—multiple sclerosis	0.000367	0.00152	CcSEcCtD
Fluorescein—Tachycardia—Dexamethasone—multiple sclerosis	0.000366	0.00151	CcSEcCtD
Fluorescein—Tachycardia—Betamethasone—multiple sclerosis	0.000366	0.00151	CcSEcCtD
Fluorescein—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000362	0.0015	CcSEcCtD
Fluorescein—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000362	0.0015	CcSEcCtD
Fluorescein—Malaise—Prednisone—multiple sclerosis	0.00036	0.00149	CcSEcCtD
Fluorescein—Syncope—Prednisone—multiple sclerosis	0.000358	0.00148	CcSEcCtD
Fluorescein—Urticaria—Prednisolone—multiple sclerosis	0.000357	0.00147	CcSEcCtD
Fluorescein—Cardiac disorder—Methotrexate—multiple sclerosis	0.000356	0.00147	CcSEcCtD
Fluorescein—Pain—Triamcinolone—multiple sclerosis	0.000353	0.00146	CcSEcCtD
Fluorescein—Loss of consciousness—Prednisone—multiple sclerosis	0.000351	0.00145	CcSEcCtD
Fluorescein—Hypotension—Dexamethasone—multiple sclerosis	0.00035	0.00145	CcSEcCtD
Fluorescein—Hypotension—Betamethasone—multiple sclerosis	0.00035	0.00145	CcSEcCtD
Fluorescein—Angiopathy—Methotrexate—multiple sclerosis	0.000348	0.00144	CcSEcCtD
Fluorescein—Vomiting—Mitoxantrone—multiple sclerosis	0.000348	0.00144	CcSEcCtD
Fluorescein—Immune system disorder—Methotrexate—multiple sclerosis	0.000347	0.00143	CcSEcCtD
Fluorescein—Convulsion—Prednisone—multiple sclerosis	0.000346	0.00143	CcSEcCtD
Fluorescein—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000346	0.00143	CcSEcCtD
Fluorescein—Hypertension—Prednisone—multiple sclerosis	0.000345	0.00143	CcSEcCtD
Fluorescein—Rash—Mitoxantrone—multiple sclerosis	0.000345	0.00143	CcSEcCtD
Fluorescein—Dermatitis—Mitoxantrone—multiple sclerosis	0.000345	0.00142	CcSEcCtD
Fluorescein—Chills—Methotrexate—multiple sclerosis	0.000344	0.00142	CcSEcCtD
Fluorescein—Headache—Mitoxantrone—multiple sclerosis	0.000343	0.00142	CcSEcCtD
Fluorescein—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00034	0.00141	CcSEcCtD
Fluorescein—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000339	0.0014	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000338	0.0014	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000337	0.00139	CcSEcCtD
Fluorescein—Paraesthesia—Dexamethasone—multiple sclerosis	0.000336	0.00139	CcSEcCtD
Fluorescein—Paraesthesia—Betamethasone—multiple sclerosis	0.000336	0.00139	CcSEcCtD
Fluorescein—Discomfort—Prednisone—multiple sclerosis	0.000336	0.00139	CcSEcCtD
Fluorescein—Erythema—Methotrexate—multiple sclerosis	0.000334	0.00138	CcSEcCtD
Fluorescein—Hypersensitivity—Prednisolone—multiple sclerosis	0.000331	0.00137	CcSEcCtD
Fluorescein—Urticaria—Triamcinolone—multiple sclerosis	0.000328	0.00135	CcSEcCtD
Fluorescein—Urticaria—Methylprednisolone—multiple sclerosis	0.000327	0.00135	CcSEcCtD
Fluorescein—Dysgeusia—Methotrexate—multiple sclerosis	0.000327	0.00135	CcSEcCtD
Fluorescein—Oedema—Prednisone—multiple sclerosis	0.000326	0.00135	CcSEcCtD
Fluorescein—Anaphylactic shock—Prednisone—multiple sclerosis	0.000326	0.00135	CcSEcCtD
Fluorescein—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000326	0.00135	CcSEcCtD
Fluorescein—Nausea—Mitoxantrone—multiple sclerosis	0.000325	0.00134	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000323	0.00134	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000323	0.00134	CcSEcCtD
Fluorescein—Shock—Prednisone—multiple sclerosis	0.000321	0.00133	CcSEcCtD
Fluorescein—Pain—Betamethasone—multiple sclerosis	0.00032	0.00132	CcSEcCtD
Fluorescein—Pain—Dexamethasone—multiple sclerosis	0.00032	0.00132	CcSEcCtD
Fluorescein—Nervous system disorder—Prednisone—multiple sclerosis	0.00032	0.00132	CcSEcCtD
Fluorescein—Tachycardia—Prednisone—multiple sclerosis	0.000318	0.00132	CcSEcCtD
Fluorescein—Skin disorder—Prednisone—multiple sclerosis	0.000317	0.00131	CcSEcCtD
Fluorescein—Hyperhidrosis—Prednisone—multiple sclerosis	0.000315	0.0013	CcSEcCtD
Fluorescein—Ill-defined disorder—Methotrexate—multiple sclerosis	0.00031	0.00128	CcSEcCtD
Fluorescein—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000309	0.00128	CcSEcCtD
Fluorescein—Feeling abnormal—Betamethasone—multiple sclerosis	0.000309	0.00128	CcSEcCtD
Fluorescein—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000306	0.00127	CcSEcCtD
Fluorescein—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000306	0.00127	CcSEcCtD
Fluorescein—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000304	0.00126	CcSEcCtD
Fluorescein—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000303	0.00125	CcSEcCtD
Fluorescein—Malaise—Methotrexate—multiple sclerosis	0.000301	0.00124	CcSEcCtD
Fluorescein—Urticaria—Betamethasone—multiple sclerosis	0.000298	0.00123	CcSEcCtD
Fluorescein—Urticaria—Dexamethasone—multiple sclerosis	0.000298	0.00123	CcSEcCtD
Fluorescein—Dizziness—Prednisolone—multiple sclerosis	0.000297	0.00123	CcSEcCtD
Fluorescein—Asthenia—Triamcinolone—multiple sclerosis	0.000296	0.00122	CcSEcCtD
Fluorescein—Abdominal pain—Dexamethasone—multiple sclerosis	0.000296	0.00122	CcSEcCtD
Fluorescein—Abdominal pain—Betamethasone—multiple sclerosis	0.000296	0.00122	CcSEcCtD
Fluorescein—Asthenia—Methylprednisolone—multiple sclerosis	0.000295	0.00122	CcSEcCtD
Fluorescein—Paraesthesia—Prednisone—multiple sclerosis	0.000293	0.00121	CcSEcCtD
Fluorescein—Pruritus—Triamcinolone—multiple sclerosis	0.000292	0.00121	CcSEcCtD
Fluorescein—Cough—Methotrexate—multiple sclerosis	0.000291	0.0012	CcSEcCtD
Fluorescein—Pruritus—Methylprednisolone—multiple sclerosis	0.000291	0.0012	CcSEcCtD
Fluorescein—Convulsion—Methotrexate—multiple sclerosis	0.000289	0.0012	CcSEcCtD
Fluorescein—Chest pain—Methotrexate—multiple sclerosis	0.000284	0.00117	CcSEcCtD
Fluorescein—Rash—Prednisolone—multiple sclerosis	0.000283	0.00117	CcSEcCtD
Fluorescein—Dermatitis—Prednisolone—multiple sclerosis	0.000283	0.00117	CcSEcCtD
Fluorescein—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000282	0.00117	CcSEcCtD
Fluorescein—Headache—Prednisolone—multiple sclerosis	0.000281	0.00116	CcSEcCtD
Fluorescein—Discomfort—Methotrexate—multiple sclerosis	0.000281	0.00116	CcSEcCtD
Fluorescein—Dizziness—Triamcinolone—multiple sclerosis	0.000273	0.00113	CcSEcCtD
Fluorescein—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000273	0.00113	CcSEcCtD
Fluorescein—Dizziness—Methylprednisolone—multiple sclerosis	0.000272	0.00113	CcSEcCtD
Fluorescein—Feeling abnormal—Prednisone—multiple sclerosis	0.000269	0.00111	CcSEcCtD
Fluorescein—Asthenia—Betamethasone—multiple sclerosis	0.000269	0.00111	CcSEcCtD
Fluorescein—Asthenia—Dexamethasone—multiple sclerosis	0.000269	0.00111	CcSEcCtD
Fluorescein—Nervous system disorder—Methotrexate—multiple sclerosis	0.000267	0.0011	CcSEcCtD
Fluorescein—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000267	0.0011	CcSEcCtD
Fluorescein—Nausea—Prednisolone—multiple sclerosis	0.000267	0.0011	CcSEcCtD
Fluorescein—Pruritus—Dexamethasone—multiple sclerosis	0.000265	0.00109	CcSEcCtD
Fluorescein—Pruritus—Betamethasone—multiple sclerosis	0.000265	0.00109	CcSEcCtD
Fluorescein—Skin disorder—Methotrexate—multiple sclerosis	0.000265	0.00109	CcSEcCtD
Fluorescein—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000264	0.00109	CcSEcCtD
Fluorescein—Vomiting—Triamcinolone—multiple sclerosis	0.000262	0.00108	CcSEcCtD
Fluorescein—Vomiting—Methylprednisolone—multiple sclerosis	0.000262	0.00108	CcSEcCtD
Fluorescein—Rash—Triamcinolone—multiple sclerosis	0.00026	0.00108	CcSEcCtD
Fluorescein—Dermatitis—Triamcinolone—multiple sclerosis	0.00026	0.00107	CcSEcCtD
Fluorescein—Rash—Methylprednisolone—multiple sclerosis	0.00026	0.00107	CcSEcCtD
Fluorescein—Dermatitis—Methylprednisolone—multiple sclerosis	0.000259	0.00107	CcSEcCtD
Fluorescein—Urticaria—Prednisone—multiple sclerosis	0.000259	0.00107	CcSEcCtD
Fluorescein—Headache—Triamcinolone—multiple sclerosis	0.000259	0.00107	CcSEcCtD
Fluorescein—Headache—Methylprednisolone—multiple sclerosis	0.000258	0.00107	CcSEcCtD
Fluorescein—Abdominal pain—Prednisone—multiple sclerosis	0.000258	0.00107	CcSEcCtD
Fluorescein—Hypotension—Methotrexate—multiple sclerosis	0.000255	0.00105	CcSEcCtD
Fluorescein—Dizziness—Betamethasone—multiple sclerosis	0.000248	0.00102	CcSEcCtD
Fluorescein—Dizziness—Dexamethasone—multiple sclerosis	0.000248	0.00102	CcSEcCtD
Fluorescein—Nausea—Triamcinolone—multiple sclerosis	0.000245	0.00101	CcSEcCtD
Fluorescein—Paraesthesia—Methotrexate—multiple sclerosis	0.000245	0.00101	CcSEcCtD
Fluorescein—Nausea—Methylprednisolone—multiple sclerosis	0.000245	0.00101	CcSEcCtD
Fluorescein—Dyspnoea—Methotrexate—multiple sclerosis	0.000243	0.001	CcSEcCtD
Fluorescein—Hypersensitivity—Prednisone—multiple sclerosis	0.00024	0.000993	CcSEcCtD
Fluorescein—Vomiting—Dexamethasone—multiple sclerosis	0.000238	0.000984	CcSEcCtD
Fluorescein—Vomiting—Betamethasone—multiple sclerosis	0.000238	0.000984	CcSEcCtD
Fluorescein—Rash—Dexamethasone—multiple sclerosis	0.000236	0.000976	CcSEcCtD
Fluorescein—Rash—Betamethasone—multiple sclerosis	0.000236	0.000976	CcSEcCtD
Fluorescein—Dermatitis—Betamethasone—multiple sclerosis	0.000236	0.000975	CcSEcCtD
Fluorescein—Dermatitis—Dexamethasone—multiple sclerosis	0.000236	0.000975	CcSEcCtD
Fluorescein—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000235	0.000972	CcSEcCtD
Fluorescein—Headache—Dexamethasone—multiple sclerosis	0.000235	0.000969	CcSEcCtD
Fluorescein—Headache—Betamethasone—multiple sclerosis	0.000235	0.000969	CcSEcCtD
Fluorescein—Asthenia—Prednisone—multiple sclerosis	0.000234	0.000967	CcSEcCtD
Fluorescein—Pain—Methotrexate—multiple sclerosis	0.000233	0.000963	CcSEcCtD
Fluorescein—Pruritus—Prednisone—multiple sclerosis	0.000231	0.000953	CcSEcCtD
Fluorescein—Feeling abnormal—Methotrexate—multiple sclerosis	0.000225	0.000928	CcSEcCtD
Fluorescein—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000223	0.000921	CcSEcCtD
Fluorescein—Nausea—Betamethasone—multiple sclerosis	0.000222	0.000919	CcSEcCtD
Fluorescein—Nausea—Dexamethasone—multiple sclerosis	0.000222	0.000919	CcSEcCtD
Fluorescein—Urticaria—Methotrexate—multiple sclerosis	0.000217	0.000895	CcSEcCtD
Fluorescein—Dizziness—Prednisone—multiple sclerosis	0.000216	0.000891	CcSEcCtD
Fluorescein—Abdominal pain—Methotrexate—multiple sclerosis	0.000215	0.00089	CcSEcCtD
Fluorescein—Vomiting—Prednisone—multiple sclerosis	0.000207	0.000857	CcSEcCtD
Fluorescein—Rash—Prednisone—multiple sclerosis	0.000206	0.00085	CcSEcCtD
Fluorescein—Dermatitis—Prednisone—multiple sclerosis	0.000205	0.000849	CcSEcCtD
Fluorescein—Headache—Prednisone—multiple sclerosis	0.000204	0.000844	CcSEcCtD
Fluorescein—Hypersensitivity—Methotrexate—multiple sclerosis	0.000201	0.00083	CcSEcCtD
Fluorescein—Asthenia—Methotrexate—multiple sclerosis	0.000196	0.000808	CcSEcCtD
Fluorescein—Nausea—Prednisone—multiple sclerosis	0.000194	0.000801	CcSEcCtD
Fluorescein—Pruritus—Methotrexate—multiple sclerosis	0.000193	0.000797	CcSEcCtD
Fluorescein—Dizziness—Methotrexate—multiple sclerosis	0.00018	0.000745	CcSEcCtD
Fluorescein—Vomiting—Methotrexate—multiple sclerosis	0.000173	0.000716	CcSEcCtD
Fluorescein—Rash—Methotrexate—multiple sclerosis	0.000172	0.00071	CcSEcCtD
Fluorescein—Dermatitis—Methotrexate—multiple sclerosis	0.000172	0.000709	CcSEcCtD
Fluorescein—Headache—Methotrexate—multiple sclerosis	0.000171	0.000706	CcSEcCtD
Fluorescein—Nausea—Methotrexate—multiple sclerosis	0.000162	0.000669	CcSEcCtD
Fluorescein—ABCC1—S1P1 pathway—S1PR1—multiple sclerosis	4.64e-05	0.0886	CbGpPWpGaD
Fluorescein—ABCC1—Sphingosine 1-phosphate (S1P) pathway—S1PR1—multiple sclerosis	4.28e-05	0.0818	CbGpPWpGaD
Fluorescein—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	4.12e-05	0.0788	CbGpPWpGaD
Fluorescein—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	4.12e-05	0.0788	CbGpPWpGaD
Fluorescein—ABCC1—Irinotecan Pathway—BCHE—multiple sclerosis	2.74e-05	0.0524	CbGpPWpGaD
Fluorescein—ABCB11—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	2.35e-05	0.0449	CbGpPWpGaD
Fluorescein—ABCB11—Recycling of bile acids and salts—ALB—multiple sclerosis	1.55e-05	0.0295	CbGpPWpGaD
Fluorescein—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.35e-05	0.0258	CbGpPWpGaD
Fluorescein—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	1.17e-05	0.0224	CbGpPWpGaD
Fluorescein—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	1.17e-05	0.0224	CbGpPWpGaD
Fluorescein—CYP1A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	1.16e-05	0.0221	CbGpPWpGaD
Fluorescein—CYP1A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	1.16e-05	0.0221	CbGpPWpGaD
Fluorescein—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	1.14e-05	0.0218	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	1e-05	0.0192	CbGpPWpGaD
Fluorescein—CYP1A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	9.5e-06	0.0181	CbGpPWpGaD
Fluorescein—CYP1A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	9.5e-06	0.0181	CbGpPWpGaD
Fluorescein—ABCB11—Bile acid and bile salt metabolism—ALB—multiple sclerosis	8.08e-06	0.0154	CbGpPWpGaD
Fluorescein—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	7.97e-06	0.0152	CbGpPWpGaD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	6.84e-06	0.0131	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	6.31e-06	0.012	CbGpPWpGaD
Fluorescein—ABCC1—S1P1 pathway—MAPK1—multiple sclerosis	6.28e-06	0.012	CbGpPWpGaD
Fluorescein—CYP1A1—Estrogen Receptor Pathway—STAT3—multiple sclerosis	5.57e-06	0.0106	CbGpPWpGaD
Fluorescein—CYP1A1—Melatonin metabolism and effects—APOE—multiple sclerosis	5.49e-06	0.0105	CbGpPWpGaD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	5.18e-06	0.0099	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—CYP27B1—multiple sclerosis	5.05e-06	0.00964	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—CYP24A1—multiple sclerosis	5.05e-06	0.00964	CbGpPWpGaD
Fluorescein—CYP1A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.98e-06	0.00951	CbGpPWpGaD
Fluorescein—CYP1A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.98e-06	0.00951	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.33e-06	0.00827	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.33e-06	0.00827	CbGpPWpGaD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.62e-06	0.00692	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.48e-06	0.00664	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.33e-06	0.00636	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.25e-06	0.00621	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.25e-06	0.00621	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—SRM—multiple sclerosis	2.74e-06	0.00523	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	2.71e-06	0.00518	CbGpPWpGaD
Fluorescein—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.64e-06	0.00503	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.63e-06	0.00503	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.52e-06	0.00482	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	2.42e-06	0.00462	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	2.41e-06	0.0046	CbGpPWpGaD
Fluorescein—CYP1A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.14e-06	0.00408	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.08e-06	0.00398	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—SRM—multiple sclerosis	2.06e-06	0.00393	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.99e-06	0.00381	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.94e-06	0.0037	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.94e-06	0.0037	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP27B1—multiple sclerosis	1.93e-06	0.00368	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—CYP24A1—multiple sclerosis	1.93e-06	0.00368	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.88e-06	0.0036	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	1.88e-06	0.0036	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	1.88e-06	0.00359	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	1.84e-06	0.00352	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.84e-06	0.00352	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—GPC5—multiple sclerosis	1.76e-06	0.00337	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.76e-06	0.00337	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1.76e-06	0.00335	CbGpPWpGaD
Fluorescein—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	1.76e-06	0.00335	CbGpPWpGaD
Fluorescein—ABCC1—Disease—GPC5—multiple sclerosis	1.58e-06	0.00302	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—RRM1—multiple sclerosis	1.46e-06	0.00279	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP27B1—multiple sclerosis	1.45e-06	0.00277	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—CYP24A1—multiple sclerosis	1.45e-06	0.00277	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.42e-06	0.0027	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—GPC5—multiple sclerosis	1.32e-06	0.00253	CbGpPWpGaD
Fluorescein—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	1.3e-06	0.00249	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—SRM—multiple sclerosis	1.22e-06	0.00234	CbGpPWpGaD
Fluorescein—CYP1A1—Biological oxidations—POMC—multiple sclerosis	1.13e-06	0.00217	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.13e-06	0.00217	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—RRM1—multiple sclerosis	1.1e-06	0.0021	CbGpPWpGaD
Fluorescein—ABCC1—Disease—RPL5—multiple sclerosis	1.03e-06	0.00197	CbGpPWpGaD
Fluorescein—ABCC1—Disease—SLC11A1—multiple sclerosis	9.85e-07	0.00188	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.74e-07	0.00186	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.88e-07	0.0017	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	8.63e-07	0.00165	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	8.63e-07	0.00165	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.52e-07	0.00163	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	8.43e-07	0.00161	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—BCHE—multiple sclerosis	8.39e-07	0.0016	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—GPC5—multiple sclerosis	7.89e-07	0.00151	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CD28—multiple sclerosis	7.87e-07	0.0015	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.32e-07	0.0014	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.67e-07	0.00127	CbGpPWpGaD
Fluorescein—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.63e-07	0.00127	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—RRM1—multiple sclerosis	6.54e-07	0.00125	CbGpPWpGaD
Fluorescein—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.34e-07	0.00121	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—BCHE—multiple sclerosis	6.31e-07	0.0012	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CD86—multiple sclerosis	5.61e-07	0.00107	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	5.07e-07	0.000969	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—APOE—multiple sclerosis	5.05e-07	0.000965	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CCR5—multiple sclerosis	4.98e-07	0.000951	CbGpPWpGaD
Fluorescein—ABCC1—Disease—HLA-A—multiple sclerosis	4.85e-07	0.000927	CbGpPWpGaD
Fluorescein—ABCC1—Disease—APOE—multiple sclerosis	4.53e-07	0.000865	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	4.36e-07	0.000833	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—POMC—multiple sclerosis	4.34e-07	0.000829	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CD80—multiple sclerosis	4.1e-07	0.000782	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.97e-07	0.000759	CbGpPWpGaD
Fluorescein—ABCB11—Metabolism—ALB—multiple sclerosis	3.95e-07	0.000755	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—APOE—multiple sclerosis	3.79e-07	0.000725	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—BCHE—multiple sclerosis	3.76e-07	0.000717	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TYK2—multiple sclerosis	3.46e-07	0.00066	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—POMC—multiple sclerosis	3.26e-07	0.000622	CbGpPWpGaD
Fluorescein—ABCC1—Disease—CD4—multiple sclerosis	3.13e-07	0.000597	CbGpPWpGaD
Fluorescein—ABCC1—Metabolism—ALB—multiple sclerosis	2.97e-07	0.000568	CbGpPWpGaD
Fluorescein—ABCC1—Disease—STAT3—multiple sclerosis	2.42e-07	0.000462	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—APOE—multiple sclerosis	2.26e-07	0.000432	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MYC—multiple sclerosis	2.25e-07	0.00043	CbGpPWpGaD
Fluorescein—ABCC1—Disease—TGFB1—multiple sclerosis	2.24e-07	0.000429	CbGpPWpGaD
Fluorescein—ABCC1—Disease—MAPK1—multiple sclerosis	2.2e-07	0.00042	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—POMC—multiple sclerosis	1.94e-07	0.000371	CbGpPWpGaD
Fluorescein—CYP1A1—Metabolism—ALB—multiple sclerosis	1.77e-07	0.000338	CbGpPWpGaD
Fluorescein—ABCC1—Disease—IL6—multiple sclerosis	1.69e-07	0.000323	CbGpPWpGaD
